NUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10MG

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,07 report with the FDA on 2010-03-10 for NUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10MG manufactured by Genentech, Inc..

Event Text Entries

[1524901] Pain at injection site, medication leaking from cartridge/needle [injection site pain]. Case description: this case, (b)(4), is a spontaneous report from the united states referring to a male patient (age not reported). The patient's relative reported this case. Concurrent conditions present at the time of the event included scoliosis. No past medical history, concomitant medications, or allergies were reported. On a date not reported, "(b)(6) ago", the patient received nutropin aq, ("2. 2 mg alternating with 2. 4 mg", qd subcutaneous) via nutropin aq pen, for the indication of growth hormone deficiency. The lot numbers for nutropin aq and the nutropin aq pen were unknown. The first puncture date was not reported. The patient's prior history of exposure to the unknown lot numbers was not reported. This was the only dose of nutropin aq administered with the nutropin aq pen prior to the event. On a date not reported, "(b)(6) ago", the patient presented with pain at injection site, medication leaking from cartridge/needle (pain injection site). The patient was unsure if he received the full dose due to the leaking cartridge, and the patient rotated injection sites on his legs. No relevant laboratory tests or treatment were reported. It was not reported whether the patient continued or discontinued use with the unknown lot numbers. It was not reported whether the patient switched to another lot number. Action taken with nutropin aq and nutropin aq pen in response to the event was not reported. The event outcome was not reported. The patient's relative assessed the event pain injection site as related to nutropin aq and the nutropin aq pen because the patient had not experienced pain with the previous brand of growth hormone. No other possible etiological factors were reported. This event was forwarded to genentech product quality and assigned the (b)(4). Additional information is being requested. If received, the case will be updated accordingly.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2917293-2010-00005
MDR Report Key1652345
Report Source04,07
Date Received2010-03-10
Date of Report2010-02-10
Date Mfgr Received2010-02-10
Date Added to Maude2012-03-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactJAMES NICKAS, PHARM.D.
Manufacturer Street1 DNA WAY
Manufacturer CitySOUTH SAN FRANCISCO CA 94080
Manufacturer CountryUS
Manufacturer Postal94080
Manufacturer Phone6502255591
Manufacturer G1GENENTECH, INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10MG
Generic NameNONE
Product CodeKZE
Date Received2010-03-10
Lot NumberUNK
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerGENENTECH, INC.


Patients

Patient NumberTreatmentOutcomeDate
10 2010-03-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.